Dalgarno, David C.,Huang, Wei-Sheng,Shakespeare, William C.,Wang, Yihan,Zhu, Xiaotian
申请号：
AU2012250517
公开号：
AU2012250517A1
申请日:
2012.05.04
申请国别(地区):
AU
年份:
2013
代理人:
摘要：
The invention features compounds, pharmaceutical compositions and methods for treating patients who have an EGFR-driven cancer of formula (I), wherein the variables are as defined herein.
